Publications: Other

2000 to Present:

  • Li Y, Metcalf BJ, Chochua S, et al. Validation of β-lactam minimum inhibitory concentration predictions for pneumococcal isolates with newly encountered penicillin binding protein (PBP) sequencesExternal. BMC Genomics. 2017;18(1):621.
  • Fridkin SK, Cleveland AA, See I, Lynfield R. Emerging Infections Program as surveillance for antimicrobial drug resistance. Emerg Infect Dis. 2015;21(9):1578–81.
  • Hadler JL, Vugia DJ, Bennett NM, Moore MR. Emerging Infections Program efforts to address health equity. Emerg Infect Dis. 2015;21(9):1589–94.
  • Hadler JL, Danila RN, Cieslak PR, et al. Emerging Infections Program–State health department perspective. Emerg Infect Dis. 2015;21(9):1510–5.
  • Langley G, Schaffner W, Farley MM, et al. Twenty years of Active Bacterial Core surveillance. Emerg Infect Dis. 2015;21(9):1520–8.
  • Langley G, Besser J, Iwamoto M, et al. Effect of culture-independent diagnostic tests on future Emerging Infections Program surveillance. Emerg Infect Dis. 2015;21(9):1582–8.
  • Lynfield R, Schaffner W. Emerging Infections Program–20 years of achievements and future prospects. Emerg Infect Dis. 2015;21(9):1497–8.
  • Pinner RW, Lynfield R, Hadler JL, et al. Cultivation of an adaptive domestic network for surveillance and evaluation of emerging infections. Emerg Infect Dis. 2015;21(9):1499–509.
  • Vugia DJ, Meek JI, Danila RN, et al. Training in infectious disease epidemiology through the Emerging Infections Program sites. Emerg Infect Dis. 2015;21(9):1516–9.
  • Olsen R, Fittipalide N, Kachroo P, et al. Clinical laboratory response to a mock outbreak of invasive bacterial infections: A preparedness study. J Clin Microbiol. 2014;2(12):4210-6.
  • Srinivasan V, Metcalf BJ, Knipe KM, et al. vanG element insertions within a conserved chromosomal site conferring vancomycin resistance to Streptococcus agalactiae and Streptococcus anginosu MBio. 2014;5(4):e01386-14.
  • Whitney CG, Zhou F, Singleton J, Schuchat A. Benefits from immunization during the vaccines for children program era – United States, 1994-2013. MMWR Morb Mortal Wkly Rep. 2014;63(16):352-5.
  • Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013. Atlanta, GA: US Department of Health and Human Services, CDC; 2013.
  • Dawood FS, Chaves SS, Pérez A, et al. Complications and associated bacterial co-infections among children hospitalized with seasonal or pandemic influenza, United States, 2003-2010. J Infect Dis. 2014;209(5):686–94.
  • Deutscher M, Lewis M, Zell ER, et al. Incidence and severity of invasive Streptococcus pneumoniae, group A Streptococcus, and group B Streptococcus infections among pregnant and postpartum women. Clin Infect Dis. 2011;53(2):114-23.
  • Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J. 2011;30(11):937-41.
  • Burton DC, Flannery B, Bennett NM, et al. Socioeconomic and racial/ethinic disparities in the incidence of bacteremic pneumonia among US adults. Am J Public Health. 2010;100(10):1904-11.
  • Van Beneden C, Olsen S, Skoff T, Lynfield R. Active, population-based surveillance for infectious diseases. In: M’ikanatha NL R; Van Beneden CA; de Valk H, ed. Infectious Disease Surveillance. 1st ed: Blackwell Publishers, pp. 32-43, 2007.
  • Begier EM, Barrett NL, Mshar PA, Johnson DG, Hadler JL, Connecticut Bioterrorism Field Epidemiology Response Team. Gram-positive rod surveillance for early anthrax detection. Emerg Infect Dis. 2005;11(9):1483-6.
  • Pinner RW, Rebmann CA, Schuchat A, Hughes JM. Disease surveillance and the academic, clinical, and public health communities. Emerg Infect Dis. 2003;9(7):781-7.
  • Centers for Disease Control and Prevention. HIV testing among pregnant women, United States and Canada, 1998-2001. MMWR Morb Mortal Wkly Rep. 2002;51(45):1013-6.
  • Hyde T, Hilger T, Reingold A, Farley MM, O’Brien, Schuchat A. Trends in incidence and antimicrobial resistance of early-onset sepsis: Population-based surveillance in San Francisco and Atlanta. Pediatrics. 2002;110:690-5.
  • Schuchat A, Hilger T, Zell E, et al. Update from the Active Bacterial Core surveillance of the Emerging Infections Program network. Emerg Infect Dis. 2001;7(1):92-9.
  • Centers for Disease Control and Prevention. Laboratory capacity to detect antimicrobial resistance, 1998. MMWR Morb Mortal Wkly Rep. 2000;48(51):1167-71.

 Top of Page

1995-1999:

  • Mead PS, Slutsker L, Dietz V, et al. Food-related illness and death in the United States. Emerg Infect Dis. 1999;5(5):607-25.